Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Market Analysis & Valuation

UpdatedAug 21, 2026
DataAggregated Company Financials
Companies7727
  • 7D-2.1%
  • 3M1.9%
  • 1Y18.8%
  • YTD9.8%

The Healthcare sector gained 3.6% while the market remained flat over the last week. Meanwhile, the market is actually up 20% over the past year. Earnings are forecast to grow by 17% annually.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.S. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 21 Aug 2026US$77.2tUS$25.1tUS$2.7t19x28.3x3.1x
Sun, 19 Jul 2026US$79.6tUS$24.4tUS$2.5t19.2x31.8x3.3x
Tue, 16 Jun 2026US$80.3tUS$24.3tUS$2.5t18.9x32.6x3.3x
Thu, 14 May 2026US$72.3tUS$24.1tUS$2.4t18.7x29.9x3x
Sat, 11 Apr 2026US$71.8tUS$23.7tUS$2.3t19.2x31.1x3x
Mon, 09 Mar 2026US$70.7tUS$23.7tUS$2.3t18.9x30.8x3x
Wed, 04 Feb 2026US$73.2tUS$23.9tUS$2.3t19.3x31.3x3.1x
Fri, 02 Jan 2026US$71.6tUS$23.2tUS$2.3t18.8x31.3x3.1x
Sun, 30 Nov 2025US$71.7tUS$23.1tUS$2.3t18.7x31.5x3.1x
Tue, 28 Oct 2025US$71.8tUS$22.8tUS$2.3t18.9x31.9x3.1x
Thu, 25 Sep 2025US$70.3tUS$22.9tUS$2.2t19.3x32.2x3.1x
Sat, 23 Aug 2025US$66.7tUS$23.0tUS$2.2t19.3x30.9x2.9x
Mon, 21 Jul 2025US$65.3tUS$22.5tUS$2.1t18.7x31x2.9x
Wed, 18 Jun 2025US$63.0tUS$22.5tUS$2.1t17.7x30x2.8x
Fri, 16 May 2025US$61.6tUS$22.4tUS$2.1t17.8x29.4x2.7x
Sun, 13 Apr 2025US$55.4tUS$21.9tUS$2.1t16.3x26.9x2.5x
Tue, 11 Mar 2025US$60.1tUS$21.9tUS$2.0t17.1x29.3x2.7x
Thu, 06 Feb 2025US$63.7tUS$21.8tUS$2.0t18.7x31.6x2.9x
Sat, 04 Jan 2025US$61.7tUS$22.0tUS$1.9t18.4x31.8x2.8x
Mon, 02 Dec 2024US$63.7tUS$22.0tUS$1.9t19.6x33x2.9x
Wed, 30 Oct 2024US$60.5tUS$21.7tUS$1.9t18.2x32.3x2.8x
Fri, 27 Sep 2024US$59.3tUS$21.6tUS$1.9t18.3x31.8x2.7x
Sun, 25 Aug 2024US$58.1tUS$21.5tUS$1.8t18.1x31.5x2.7x
Tue, 23 Jul 2024US$57.2tUS$21.3tUS$1.8t17.9x31x2.7x
Thu, 20 Jun 2024US$56.7tUS$21.3tUS$1.8t16.6x30.9x2.7x
Sat, 18 May 2024US$55.1tUS$21.2tUS$1.8t17.5x30.4x2.6x
Mon, 15 Apr 2024US$53.2tUS$21.1tUS$1.8t16.6x28.8x2.5x
Wed, 13 Mar 2024US$53.3tUS$21.1tUS$1.8t16.6x28.9x2.5x
Fri, 09 Feb 2024US$51.7tUS$21.0tUS$1.8t16.2x29x2.5x
Sun, 07 Jan 2024US$49.3tUS$21.0tUS$1.8t16.7x28x2.3x
Tue, 05 Dec 2023US$48.1tUS$21.0tUS$1.8t16.2x27.4x2.3x
Thu, 02 Nov 2023US$43.9tUS$21.0tUS$1.7t15x25.5x2.1x
Sat, 30 Sep 2023US$45.4tUS$21.0tUS$1.7t15.4x26.5x2.2x
Mon, 28 Aug 2023US$46.3tUS$20.9tUS$1.7t15.6x27x2.2x
Price to Earnings Ratio

27x


Total Market Cap: US$46.3tTotal Earnings: US$1.7tTotal Revenue: US$20.9tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Market Price to Earnings3Y Average 30.2x202420252026
Current Market PE
  • Investors are relatively neutral on the American market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading close to its 3-year average PE ratio of 30.2x.
Past Earnings Growth
  • The earnings for American listed companies have grown 17% per year over the last three years.
  • Revenues for these companies have grown 6.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Sector Trends

Which sectors have driven the changes within the U.S. Market?

US Market-2.09%
Energy3.68%
Healthcare2.40%
Materials2.01%
Real Estate-0.10%
Consumer Discretionary-1.03%
Utilities-1.14%
Financials-2.43%
Telecom-2.70%
Consumer Staples-2.75%
Tech-3.71%
Industrials-3.75%
Sector PE
  • Investors favour the Healthcare sector the most for future growth, which is trading close to its 3-year average PE ratio of 65.5x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 20.2%, which is higher than its past year's earnings growth of 17.4% per year.
  • The Financials sector is the least preferred by investors for future growth, which is trading close to its 3-year average of 17.5x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 23% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Energy sector is expected to see its earnings grow by 6.1% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
AAPL AppleUS$311.302.0%
+US$88.1b		38.4%PE35.2xTech
MRK MerckUS$148.999.9%
+US$33.2b		73.1%PE115.8xHealthcare
LLY Eli LillyUS$1.24k2.9%
+US$31.6b		75.3%PE41.5xHealthcare
XOM ExxonMobil HoldingsUS$166.154.8%
+US$31.0b		52.1%PE20.9xEnergy
MRNA ModernaUS$133.32110.5%
+US$27.9b		391.6%PS23.9xHealthcare
See more

Market Insights

Header cover image
Every new payment app was supposed to kill Visa and Mastercard. Instead, they got bigger. So what does that mean for the payment stocks on your radar?
Continue reading
Picking portfolio winners takes more than hot air

Latest News

AAPL
US$311.30
Apple
7D
2.0%
1Y
38.4%
Seeking Alpha • 3h

Apple's Immunity To Headwinds Is Fading (Rating Downgrade)

Summary Apple is downgraded to a sell rating due to unjustified valuation premiums amid deteriorating growth and margin prospects. Q3 results were robust, with 16.36% YoY revenue growth and significant margin expansion, but Q4 guidance signals deceleration and potential gross margin contraction. Cost pressures, especially in memory and components, threaten future profitability, while attempts to mitigate them via CXMT chips face political and pricing obstacles. Potential catalysts like the Alibaba AI partnership and new product launches exist, but rising risks and premium multiples outweigh the positives. Read the full article on Seeking Alpha
AMD
US$469.46
Advanced Micro Devices
7D
-8.7%
1Y
179.8%
MRK
US$148.99
Merck
7D
9.9%
1Y
73.1%
MRNA
US$133.32
Moderna
7D
110.5%
1Y
391.6%
META
US$545.83
Meta Platforms
7D
-7.5%
1Y
-27.7%
AVGO
US$364.03
Broadcom
7D
-7.4%
1Y
23.8%
Seeking Alpha • 12h

Broadcom: Marvell Panic Causes A Huge Buying Opportunity

Summary Broadcom Inc. remains a prime beneficiary of the AI boom, with robust profit growth expected for years. The recent selloff following the Marvell-Alphabet deal is seen as an overreaction; the partnership does not threaten AVGO’s position or growth trajectory. AVGO’s valuation is compelling, with downside risk already priced in even under conservative growth assumptions. Even with bearish growth scenarios, AVGO offers attractive annualized returns of 12%+, with potential for much higher upside if consensus is met or exceeded. Read the full article on Seeking Alpha
MRVL
US$251.01
Marvell Technology
7D
13.1%
1Y
243.8%
LLY
US$1,244.40
Eli Lilly
7D
2.9%
1Y
75.3%
GOOGL
US$340.67
Alphabet
7D
-1.5%
1Y
65.3%
TSLA
US$345.13
Tesla
7D
1.5%
1Y
7.8%
VMRK
US$65.14
Vivmark Residential
7D
-1.1%
1Y
-4.5%
New Narrative • Aug 19

Tight Occupancy And High-Yield Development Pipeline Will Support Long-Term Earnings Quality

Catalysts About Vivmark Residential Vivmark Residential develops, owns and operates multifamily rental communities with a focus on large coastal and select expansion markets. What are the underlying business or industry changes driving this perspective?
SPCX
US$134.00
Space Exploration Technologies
7D
-5.2%
1Y
n/a
Narrative Update • Aug 19

SPCX: AI And Tokenization Optionality Will Sustain Long-Term Upside Potential

Analysts trimmed the Space Exploration Technologies fair value estimate to $213.50 from $223.00, as a slightly higher discount rate and lower projected profit margins outweighed stronger modeled revenue growth and a higher future P/E tied to ongoing enthusiasm for AI and tokenization driven demand, Starlink expansion, and Starship related optionality. Analyst Commentary Recent Street research on Space Exploration Technologies shows a wide spread of views on how sustainable the current valuation is and how much credit to give the company for AI, Starlink and Starship related optionality.
MSFT
US$481.15
Microsoft
7D
-2.9%
1Y
-5.1%
Narrative Update • Aug 19

MSFT: AI Infrastructure And Custom Chips Will Sustain Premium Earnings Multiples

Microsoft's updated analyst price target framework reflects a higher fair value estimate of $717.92, with analysts pointing to the company's AI driven Azure and M365 Commercial Cloud growth, stronger profit margin assumptions, and a lower projected future P/E multiple as key supports for the change. Analyst Commentary Recent Street research shows a broadly constructive tone around Microsoft, with many bullish analysts updating price targets and reiterating confidence in the company’s AI centric cloud strategy.
XOM
US$166.15
ExxonMobil Holdings
7D
4.8%
1Y
52.1%
Narrative Update • Aug 18

XOM: Tighter Oil Supply And Iran Risk Will Reprice Shares Higher

ExxonMobil Holdings' fair value estimate has shifted from $185.00 to about $194.86 as analysts factor in updated Q2 earnings research, including mixed revisions to price targets and views on cash flow strength and longer term P/E assumptions. Analyst Commentary Recent Street research on ExxonMobil Holdings shows a wide range of views, but the overall message for investors is that the stock still attracts meaningful support even as some firms trim price targets or move to more neutral ratings.
NVDA
US$216.85
NVIDIA
7D
-3.8%
1Y
23.9%
New Narrative • Aug 17

NVDA Is Priced for a Decade of Growth — The Real Risk Is "How Long," Not "If"

NVIDIA posted $81.6B in Q1 FY27 revenue (+85% YoY), with the Data Center segment up 92% YoY to $75.2B. Q2 FY27 guidance ($91.0B ±2%, reporting August 26, 2026) implies sequential momentum is intact — though management explicitly excludes any Data Center compute revenue from China, a reminder that reported growth no longer includes that market.
WMT
US$103.84
Walmart
7D
-10.3%
1Y
6.0%
Seeking Alpha • Aug 17

Walmart: Earnings Setup As Consumer Tailwinds Turn Into Headwinds In The Second Half

Summary Walmart maintains a hold rating due to its premium valuation and mixed technical outlook ahead of Q2 earnings. WMT's Q1 results showed solid revenue and eCommerce growth, but cautious guidance and elevated costs weighed on sentiment. Management reaffirmed FY 2027 guidance, projecting 3.5%-4.5% net sales growth and $2.75-$2.85 adjusted EPS, disappointing those hoping for upgrades. Technical signals suggest sideways price action, with key resistance at $122 and support at $105 amid ongoing valuation concerns. Read the full article on Seeking Alpha